− cells is negligible during homeostasis and moderate proliferative stress. In such settings, peripheral compartmentalized self-renewal can maintain the composition of distinct, differentiated NK cell subpopulations.
INTRODUCTION
Natural killer (NK) cells are defined as lymphocytes capable of target cell killing and cytokine production independent of somatic recombination-activating gene-mediated antigen receptor recombination. Thereby, distinguished from adaptive T and B cells, this fact precludes clonal tracking of NK cells based on receptor gene structure. In humans, NK cells have been phenotypically defined by the expression of CD56 and/or CD16, in the absence of T, B, and myeloid markers (1) . More recently, a range of markers have been used to define functionally distinct human NK cell subsets (2) (3) (4) . Models of human NK cell ontogeny have been proposed on the basis of comparative phenotyping of NK cells in the bone marrow (BM), lymph nodes (LNs), and blood; kinetics of recovery after transplantation; and in vitro culture (5, 6) . Precursor cells derived from multipotent hematopoietic stem and progenitor cells (HSPCs) have been hypothesized to migrate from the BM to the LNs, generating
CD56
bright CD16 − NK cells, followed by continuous maturation and release to maintain the predominant circulating CD56 dim CD16 + NK cell subset. Deuterium labeling and Ki-67 staining studies have estimated a half-life of 14 days for circulating human NK cells and a proliferation rate of 4 to 5% per day, interpreted as evidence for ongoing release of immature progenitors. Nonetheless, almost instantaneous appearance of labeled CD56 dim NK cells in the blood, consistent with proliferation of circulating cells, was also noted (7, 8) .
Murine NK cells were shown to respond to a specific viral or hapten exposure, conferring protective immunity upon adoptive transfer and rechallenge, uncovering unexpected memory capabilities of NK cells similar to cytotoxic effector T cells (9) . In addition, cytokine exposure has been shown to result in persistence of NK cell responses to viruses or tumors, even after adoptive transfer (10) . In humans, subsets of CD56 dim CD16
+ NK cells expand upon cytomegalovirus (CMV) infection and may represent human analogs of murine adaptive NK cells (11) (12) (13) (14) . In contrast to CD56 bright and canonical CD56 dim NK cells, human "adaptive" NK cells variegatedly lack expression of several signaling proteins and generally express killer immunoglobulin-like receptors (KIRs) and NKG2C (13, 14) . Epigenetically, adaptive NK cells approximate CD8 + effector T cells (14) , with decreased methylation at the IFNG CNS1 locus (15) , suggesting shared developmental pathways. Epigenetically imprinted "clonal" expansions in humans have been inferred by the presence of NK cells expressing distinct combinations of KIRs after CMV infection or reactivation (11, 14) . Mechanisms propagating functional NK cell diversity and memory in the absence of somatic receptor rearrangements have not been elucidated.
There are marked differences between the phenotype and function of mouse versus human NK cells (16, 17) . Human NK cells are scantly produced in immunodeficient mice, and robust in vitro clonal assays are lacking; thus, processes maintaining their homeostasis and possible memory are poorly characterized in humans. Relative to rodents, rhesus macaque (RM) NK cells are well studied, are evolutionarily close to humans, and share phenotypic and functional characteristics with human NK cells: a dominant blood CD56 − CD16
+ NK cell population, functionally resembling human CD56 dim CD16
+ NK cells, and a CD56 + CD16 − NK cell population that is dominant in LNs but is less frequent in blood, resembling human CD56 bright CD16 − NK cells (18) . Functional evidence for antigenspecific NK cell memory in RM after simian immunodeficiency virus (SIV)/HIV vaccination has been reported (19) . Whereas human and RM KIRs are evolutionarily divergent, RM Mamu-KIR3D receptors are extremely diverse, bind major histocompatibility complex (MHC) class I molecules analogous to human lineage II KIRs, and show variegated distribution demonstrated via staining with the limited number of available anti-KIR monoclonal antibodies (mAbs) and/or MHC class I tetramer binding (20) (21) (22) .
We developed a robust system of genetic "barcoding" to interrogate in vivo hematopoiesis after autologous RM HSPC transplantation, allowing tracking of clonal output from thousands of HSPCs and their progeny. In our initial report of hematopoiesis early after engraftment, we were surprised to find that most of the blood NK cells were clonally distinct from T, B, and myeloid cells derived from multipotent HSPCs (23) . The minor CD56 + CD16 − NK cell blood population was clonally related to the other lineages; however, at these early time points, the major blood population of CD56 − CD16
+ NK cells accounted for the divergence in clonal ontogeny. We interpreted these surprising results to be consistent with a distinct developmental pathway for CD56 − CD16
+ NK cells. Here, we have dissected clonal patterns in NK cells for more than 4 years, allowing a detailed long-term kinetic analysis of NK cell clonal populations in steady state and upon proliferative challenge. Our results provide direct evidence for long-term clonal expansions, persistence, and self-renewal of mature NK cells independent of progenitor cells, highlighting a previously unappreciated compartmentalization among NK cell subsets and forming the basis for a new model of NK cell dynamics. Figure S3 provides histograms validating a ratio >10:1 as clearly delineating a separate population of highly biased CD56 − CD16 + clones. When using the same criteria for comparisons with other lineages, only the T cell compartment in ZH33 showed appreciable numbers of high-contributing biased clones, developing late after transplant ( Fig. 2A and fig. S3 (18) . Antibodies that react only with human NKG2A bind to both NKG2A and NKG2C isoforms on RM NK cells (18, (25) (26) (27) (28) .
RESULTS

Low
NK cell clonal dynamics over time
To study the clonal dynamics of NK cell subpopulations, clones were grouped hierarchically into clusters within each cell type based on overall similarities of contributions over time, and the mean fractional contributions of each cluster over time were plotted. In ZH33 Grs, there were two clusters: one representing short-term engrafting progenitors that disappeared by 2 months, and the second representing very stable ongoing production from long-term clones beginning at 2 months and persisting to 49 months (Fig. 3A , left). Each clone contributed an average of less than 1% (Fig. 3A, right) . In CD56 + CD16 − cells, the major cluster shows very stable output from clones contributing an average of less than 1 to 2% per clone (Fig. 3B ). These clones were primarily multilineage, also producing T, B, and myeloid cells ( Fig. 2A) . Similar patterns emerged in additional animals ( fig. S4 ).
The CD56 − CD16 + NK cell patterns were notably different in all three animals, both in kinetics and in magnitude of individual contributions ( Fig. 3C and fig. S4 ). There were clear expansions and contractions of groups of clones over time, with some clusters composed of clones with average contributions of 6 to 8%. Plots of the changes over time for ZH33 clones shown individually are shown in fig. S5 . A similar pattern of expanding and contracting clusters was observed in T cells later after transplant in animal ZH33 (Fig. 3D ).
NK cell clonal segregation on the basis of specific cell surface receptor phenotypes KIRs are diverse and rapidly evolving receptors mediating activating and inhibitory interactions with target cells. NK cell expansions occurring coincident with CMV reactivation after transplantation in humans are frequently KIR + , with clonal-like variegated patterns of specific KIRs expressed on subsets of expanding NK cells (11, 12) . Expression of highly polymorphic and polygenic KIR genes has been described as stochastic and is presumed to be maintained epigenetically. Investigation of NK cell responses in vivo at a clonal level has been previously impossible, with no ability to link different KIR repertories to specific clonal expansions.
Many specific antibodies have been developed to detect diverse human KIRs. However, almost all human KIR antibodies lack cross-reactivity with RM KIRs, given the highly diverse and rapidly evolving nature of these loci in primates, and few RM-specific KIR antibodies have been developed (20, 29) . An anti-human KIR2D (clone NKVFS1) antibody has been shown to recognize RM KIR3DL01 (30, 31) . An alternative approach to identifying expression of specific RM KIRs has been staining with tetrameric peptide-MHC class I (pMHC-I) complexes shown to bind to KIRs and segregate RM NK cell populations with specific patterns of KIR expression (22, 32) .
We stained CD3 − NKG2 + NK cells from nine RMs with anti-human KIR2D and the RM pMHC-I tetramer SIV-Gag GY9/Mamu-A1*002. Positive and negative subpopulations after staining with these reagents were distinct and varied 
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between animals (Fig. 4, A and B) , reminiscent of observed variegated, persistent KIR expression patterns on human NK cells (11) . We sorted subpopulations of CD3
+ NK cells from four barcoded monkeys for KIR2D and pMHC-I tetramer staining and performed barcode analysis on each distinct subpopulation of sufficient size for barcode retrieval (Fig. 4B) . The highly biased and expanded CD16 +
NKG2
+ NK cell clones showed clear segregation between sorted subpopulations (Fig. 4, C and D) . For instance, in monkeys ZJ31 and ZG66, different sets of expanded clones completely segregated into the same KIR3DL01 + or KIR3DL01 − subpopulations. The clones present in the KIR3DL01 − fraction likely expressed other KIRs not reactive with available reagents. In ZH19, three major NK cell subpopulations were sorted on the basis of both KIR3DL01 and GY9/Mamu-A1*002 staining, and each population contained a set of specific clones. Within the KIR3DL01 − NK cell subset, specific GY9 + clones were enriched and contributed major fractions to this subpopulation, although, within the bulk population, these clones were relatively small contributors, for instance, nos. 8, 9, 10, and 11 at 48.5 months and no. 44 at 52.5 months (Fig. 4C ). ZK22 had no detectable KIR3DL01 + NK cells but had clear populations of GY9/Mamu-A1*002 + cells showing barcode segregation. In all four animals, clonal segregation linked to KIR expression was stable long term, documented from 9 months to 2 years (Fig. 4D) .
RMs in this study were rhesus CMV (rhCMV) + at the time of transplantation. We documented reactivation of latent rhCMV immediately after transplant ( fig. S6A) bright NK cells comparing baseline day −7 with day 36 were strongly correlated (r = 0.74; Fig. 5D ). Most highly biased individual NK cell clones present before depletion appeared again after recovery (Fig. 5C ). The overall fraction of clonal contributions to CD56 − CD16 bright NK cells derived from biased clones compared with multipotent clones decreased somewhat after recovery but remained almost 50% (Fig. 5E ). Many CD56 − CD16 dim clones were shared with CD56 − CD16 bright clones at baseline, and their overall clonal patterns were highly correlated (Fig. 5D) + compartment.
Prolonged profound in vivo NK cell depletion via anti-interleukin-15
Next, we aimed to examine NK cell dynamics upon long-lasting in vivo depletion of NK cells. Eighteen months after full recovery from anti-CD16 antibody treatment and clonal stabilization, we administered three biweekly doses of an anti-interleukin-15 (IL-15) neutralizing antibody to RM ZH33. This treatment is reported to table S1 ).
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result in a profound and very prolonged depletion of all NK cell subsets within RM blood and tissues (Fig. 6A) not begin until more than 3 months after treatment, not reaching a normal range until more than 12 months later (Fig. 6 , B and C). As reported previously, effector T cells were also depleted by this antibody (34) but to a lesser degree than NK cells and only short term (Fig. 6, B (fig. S7D) .
The highly expanded and biased NK cell clones present at baseline (day −22) were profoundly depleted after the anti-IL-15 antibody treatment, and in contrast to the effect of anti-CD16 NK cell depletion, these clones almost completely disappeared upon NK cell recovery (Fig. 6D , designated by red bars on the left of the heat map and in Fig. 6E ). Instead, new clonal expansions arose in the CD16 + NK cell compartment at day 167 after treatment, the earliest time point at which sufficient NK cells could be collected for clonal analysis. These expanded clones were present specifically in CD56 − CD16
+ cells and, in contrast to results after the less profound and shorter-term depletion induced by the anti-CD16 antibody, were not the same expanded clones present at baseline (compare clones labeled with red bars with those labeled with yellow, blue, and purple bars in Fig. 6 , D and E). Although some of these new expanded NK cell clones were biased (Fig. 6, D and E, yellow, blue, and purple bars), most contributed at detectable but relatively lower levels to T, B, Gr, and CD56 + NK cells (Fig. 6D) . In addition, expanded clones not fitting criteria for CD16 bias began contributing to this compartment after recovery (Fig. 6 , D and E, gray bars). New sets of expanded T cell clones also appeared (Fig. 6D,  green bar) . These results suggest that after profound and lasting depletion of all NK cells, including biased and expanded CD56 − CD16
+ clones, new NK cells could not be regenerated peripherally from long-lived self-renewing NK cells and instead had to be produced from longterm engrafted HSPCs also contributing to other cell lineages.
DISCUSSION
Maintenance of distinct cell populations is a function of survival, self-renewal, and differentiation. The prevailing human model posits that CD56 bright NK cells are produced from BM precursors and continuously generate CD56 dim NK cells in secondary lymphoid tissues (5, 6) + NK cells were homogeneously distributed between blood, nodes, and multiple marrow locations, suggesting that clonal expansions occur outside the marrow and nodes, even if the final steps in maturation occur in nodes (37) . As evidenced by Ki-67 staining, human blood CD56 bright NK cells were reported to cycle more rapidly than CD56 dim NK cells (8) . In the present study, we also observed higher steady-state turnover of RM CD56 (Fig. 7) . The persistence of differentiated, oligoclonal expanded NK cell clones, even in the setting of proliferative stress, also argues against the notion of mature RM CD16 + or human canonical CD56 dim NK cells as senescent (38) . This conclusion is also supported by results of clinical NK cell infusions and murine adoptive transfer studies, documenting in vivo persistence of mature NK cells for several months without dependence on regeneration from marrow HSPCs (39, 40) . We recently reported evidence from two clinical syndromes suggesting that human CD56 dim NK cells can be maintained independently of ongoing production from HSPCs, suggesting longevity and self-renewal (41, 42) . Hypothetically, high levels of homeostatic cytokines, such as IL-7 and IL-15, or even inflammatory cytokines, may be required to break the steady-state barrier between these subsets to rejuvenate the CD56 − NK cells (Fig. 7) . Identification of the precise engrafting CD34 + short-term multipotent progenitor or NK-committed precursor serving as the source of these cells is the subject of future barcoding studies.
Our observations raise important questions as to how dynamics among NK cell subpopulations is orchestrated. The segregation of specific expanded clones with distinct surface KIR expression in our model, with many individual clones being uniformly positive or negative for a given KIR, provides evidence that a single original cell that proliferated to generate this clone had already undergone the process of KIR acquisition and epigenetic stabilization and was likely a fully mature NK cell. This notable result provides clear evidence for the stability of specific clonal KIR expression patterns through multiple cell divisions, for time periods up to several years. Specific KIRs segregating with individual or groups of barcoded NK cell clones may be directly responsible for signaling expansion or may simply be stably coexpressed with other receptors driving expansion and persistence of a relatively small number of contributing clones. Whether response to a specific stimulus or stochastic factors are responsible for NK clonal expansion and persistence is unclear. Waxing and waning groups of expanded NK cell clones over time suggest an environmentally driven process. Recent reports that CMV infection can induce the differentiation of epigenetically unique and stable human adaptive or memory-like CD56 dim NK cell populations imply that RM CMV reactivation after transplantation might drive oligoclonal expansions (13, 14) and can be tested via analysis of NK cell clonal patterns in CMV − RMs after de novo CMV infection. However, we could not demonstrate the fact that RM CD56 − CD16 + NK cells expressed the signature of signaling molecules and transcription factors previously linked to human adaptive NK cells arising in the context of CMV infection. Regrettably, no antibodies reactive with RM CD57 or NKG2C exist, markers also associated with human adaptive or memory-like NK cell subsets after CMV and other viral infections, although a recent report used RNA probes and flow cytometry to distinguish NKG2C-versus NKG2A-expressing RM NK cells (43, 44) . Therefore, it remains unclear whether the RM models human adaptive NK cell differentiation and homeostasis.
In conclusion, the tracking of individual NK cell clonal histories in RMs provides direct evidence for the peripheral expansion and stable persistence of differentiated mature NK cell clones and associates these clones with stable expression of specific KIRs, offering insights into the development and maintenance of mature circulating NK cells. Under homeostatic conditions, our findings suggest a barrier between HSPC-dependent CD56 bright and the more stably maintained CD56 dim NK cell populations, providing a model for understanding NK cell differentiation and homeostasis (Fig. 7) . In addition, these findings have translational implications because development of NK cell therapies requires an understanding of how, where, and why specific NK cells are generated (45, 46) .
MATERIALS AND METHODS
Barcoded autologous transplantation model and experimental design
Animal studies were approved by the National Heart, Lung, and Blood Institute (NHLBI) Animal Care and Use Committee. RM CD34 + HSPC transductions with barcoded lentiviral libraries and autologous transplantation after 10 Gy total body irradiation were performed as previously described (23, 47) , with individual animal data summarized in fig. S1A . The transplanted product contained virtually no barcoded mature cells. Thus, barcoded hematopoiesis after engraftment was generated from CD34 + HSPCs, not from residual NK cells present in the initial graft ( fig. S1B ).
Barcode libraries with a diversity 10 times greater than that necessary to be more than 95% certain that each individual barcode marked a single CD34 + cell were used, at a transduction efficiency resulting in a single barcode per HSPC (23, 48) . DNA samples from hematopoietic lineage cells were used to amplify the barcode region via polymerase chain reaction (PCR), followed by next-generation sequencing to recover the barcodes for lineage clonal relationship analysis. Output was processed using custom Python code to identify barcoded clones contributing above sequencing error and sampling thresholds (23, 24) . Each clone's fractional contribution to a sample could then be calculated. Custom R code is available on GitHub at http://github.com/d93espinoza/ barcodetrackR.
Cell purification and fluorescence-activated cell sorting analysis Blood, LN, and BM cells were isolated on a density gradient and stained with various antibody panels for fluorescence-activated cell sorting (FACS) analyses and sorting. Antibodies are listed in table S5. Cellular subsets were FACS sorted to >98% purity using gating as shown in fig. S1C . Intracellular Ki-67 staining was performed using the eBioscience Foxp3/Transcription Factor Staining Buffer. Cells were sorted on a BD FACSAriaII sorter. All FACS data were analyzed using FlowJo. GY9/Mamu-A1*002 monomers, provided by D. A. Price (Cardiff University), were tetramerized with either phycoerythrin or allophycocyanin streptavidin and were used for staining 1 million PBMCs with 0.6 g of tetramer for 15 min at room temperature and then with other surface marker antibodies for 30 min at 4°C.
Barcode retrieval
Cell DNA was extracted with the DNeasy Kit (Qiagen). DNA (100 to 500 ng) underwent 28-cycle PCR using Phusion High-Fidelity DNA Polymerase (Thermo Fisher Scientific). A universal reverse primer and a unique forward primer (table S4) were used to multiplex sample sequencing. After gel purification, 10 to 24 multiplexed samples were then pooled for sequencing on an Illumina HiSeq 2500 or 3000. The Python code used for extraction from FASTQ files is available at https://github.com/d93espinoza/barcode_extracter.
In vivo depletion of NK cells
The mouse anti-human CD16 monoclonal NK depleting antibody (3G8) and the anti-IL-15 neutralizing antibody (M111) were obtained from the Nonhuman Primate Reagent Resource(www.nhpreagents.org) and were used for NK cell depletion, as previously described (33, 34) .
Computational and statistical analyses
Data analysis, Pearson correlations, Euclidean distances, P values, and plot generation were performed using R (Foundation for Statistical Computing) and Prism (GraphPad Software). The R code used is available online at http://github.com/d93espinoza/barcodetrackR. Table S1 . Pearson correlation coefficient r values, P values, and 95% confidence intervals for the correlation coefficient. Table S2 . Corresponding percentage contributions to the samples presented in Fig. 2A . Table S3 . The number of barcodes above threshold for each sample from ZH33, ZG66, and ZJ31 in Figs. 1 and 2 . Table S4 . Primer sequence information. Table S5 . Antibody information. Data file S1.
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